Trials / Sponsors / Chimeric Therapeutics
Chimeric Therapeutics
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Thera Neuroendocrine Tumors, Colorectal Cancer, Gastric Cancer | Phase 1 / Phase 2 | 2024-05-15 |
| Active Not Recruiting | CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma Glioblastoma Multiforme of Brain | Phase 1 | 2023-06-06 |